EyePoint EYPT
NASDAQ EYPT
$4.58 +0.01 (+0.33%)
As of: Sep 4, 2026 · 3:59 PM EDT

EyePoint (EYPT) Operating Leases (2019 - 2026)

EyePoint (EYPT) posted Operating Leases of $20.2 million for Q1 2026, down 2.61% sequentially from $20.8 million in Q4 2025, and down 9.34% YoY from $22.3 million in Q1 2025.

Analysis

EyePoint (EYPT) Operating Leases (2019 - 2026) Analysis & Trends

EyePoint has reported Operating Leases for 8 years, with the latest figure at $20.2 million in Q1 2026.

  • Quarterly Operating Leases fell 9.34% year-over-year to $20.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20.2 million (down 9.34% YoY) and the FY2025 annual result came in at $20.8 million, down 4.97% from the prior year.
  • Operating Leases slipped to $20.2 million in Q1 2026 per EYPT's latest filing, from $20.8 million in the prior quarter.
  • Over five years, Operating Leases peaked at $22.3 million in Q1 2025 and troughed at $1.7 million in Q1 2022.
  • A 5-year average of $12.7 million and a median of $6.2 million in 2022 frame the typical range for Operating Leases.
  • The sharpest annual moves came in 2022 and 2025: Operating Leases dropped 21.87% in 2022, then surged 382.57% in 2025.
  • Over 5 years, Operating Leases stood at $6.0 million in 2022, then fell by 18.01% to $4.9 million in 2023, then jumped by 345.54% to $21.9 million in 2024, then fell by 4.97% to $20.8 million in 2025, then decreased by 2.61% to $20.2 million in 2026.
  • According to Business Quant data, Operating Leases over the past three periods registered $20.2 million, $20.8 million, and $21.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 EyePoint 398.53 Mn 218.06 Mn 507,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 19.81 Mn
Mar 31, 2026 20.23 Mn
Dec 31, 2025 20.77 Mn
Sep 30, 2025 21.30 Mn
Jun 30, 2025 21.82 Mn
Mar 31, 2025 22.31 Mn
Dec 31, 2024 21.86 Mn
Sep 30, 2024 21.92 Mn
Jun 30, 2024 22.16 Mn
Mar 31, 2024 4.62 Mn
Dec 31, 2023 4.91 Mn
Sep 30, 2023 5.19 Mn
Jun 30, 2023 5.46 Mn
Mar 31, 2023 5.72 Mn
Dec 31, 2022 5.98 Mn
Sep 30, 2022 6.24 Mn
Jun 30, 2022 2.90 Mn
Mar 31, 2022 1.70 Mn
Dec 31, 2021 1.86 Mn
Sep 30, 2021 2.02 Mn